Use of Acetaminophen and Nonsteroidal Anti-inflammatory Drugs: A Prospective Study and the Risk of Symptomatic Diverticular Disease in Men

Archives of Family Medicine

Volumn 7, Issue 3, 1998, Pages 255-260

  Aldoori, Walid H ^a,c   Giovannucci, Edward L ^a,b   Rimm, Eric B ^a   Wing, Alvin L ^a   Willett, Walter C ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Whitehall Robins Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; DIVERTICULITIS; HEALTH CARE PERSONNEL; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK; RISK FACTOR; STATISTICS; UNITED STATES;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIVERTICULITIS; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; RISK FACTORS; UNITED STATES;

EID: 0032066931     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.7.3.255     Document Type: Article

References (56)

1. Walters DAK, Smith AN. Strength of the colon wall in diverticular disease. Br J Surg. 1990;77:257-259.
2. Roberts PL, Veidenheimer MC. Diverticular disease of the colon. In: Bayless TM, ed. Current Therapy in Gastroenterology and Liver Diseases.Toronto, Ontario: BC Decker Inc;1990:416-419. Series 3.
3. Schwartz JT, Graham DY.Diverticular disease of the large intestine. In: Kirsner J, Shorter R, eds. Diseases of the Colon, Rectum, and Anal Canal. Baltimore, Md: Williams & Wilkins; 1988:519-536.
4. Thompson WG, Patel DG. Clinical picture of diverticular disease of the colon. Clin Gastroenterol. 1986;15:903-916.
5. Painter NS, Burkitt DP. Diverticular disease of the colon: a 20th century problem. Clin Gastroenterol. 1975;4:3-21.
6. Painter NS, Burkitt DP. Diverticular disease of the colon: a deficiency disease of western civilization. BMJ. 1971;2:450-454.
7. Painter N. Diverticular disease of the colon. In: Trowell H, Burkitt D, Heaton K, eds. Dietary Fibre, Fibre-Depleted Foods and Diseases. London, England: Academic Press Inc; 1985:145-160.
8. Brodribb AJM, Humphreys DM. Diverticular disease: three studies, I: relation to other disorders and fiber intake. BM J. 1976;1:424-425.
9. Leaky AL, Ellis RM, Quill DS, Peel ALG. High fiber diet in symptomatic diverticular disease of the colon. Ann R Coll Surg Engl. 1985;67:173-174.
10. Manousos O, Day NE, Tzonou A, et al. Diet and other factors in the aetiology of diverticulosis: an epidemiological study in Greece. Gut. 1985;26:544-549.
11. Miettinen TA, Tarpila S. Fecal beta-sitosterol in patients with diverticular disease of the colon and in vegetarians. Scand J Gastroenterol. 1978;13:573-576.
12. Gear JSS, Ware A, Fursdon P, et al. Symptomless diverticular disease and intake of dietary fiber. Lancet. 1979;1:511-514.
13. Findlay JM, Smith AN, Mitchell WD, Anderson AJB, Eastwood MA. Effects of unprocessed bran on colon function in normal subjects and in diverticular disease. Lancet. 1974;1:146-149.
14. Hodgson, WJB. An interim report on the production of colonic diverticula in the rabbit. Gut. 1972;13:802-804.
15. Fisher N, Berry CS, Fearn T, Gregory JA, Hardy J. Cereal dietary fiber consumption and diverticular disease: a lifespan study in rats. Am J Clin Nutr. 1985;42:788-804.
16. Jaskiewicz K, Rossouw JE, Kritchevsky D, Van Resburg SJ, Fincham JE, Woodroof CW. The influence of diet and diemethyhydrazine on the small and large intestine of Vervet monkeys. Br J Exp Pathol. 1986;67:361-369.
17. Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Trichopoulos DV, Willett WC. A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr. 1994;60:757-764.
18. Aldoori WH, Giovannucci EL, Rimm EB, et al. A prospective study of physical activity and the risk of symptomatic diverticular disease in men. Gut. 1995;36:276-282.
19. Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Trichopoulos DV, Willett WC. A prospective study of alcohol, smoking, caffeine and the risk of symptomatic diverticular disease in men. Ann Epidemiol. 1995;5:221-228.
20. Coutrot S, Roland D, Barbier J, Van Der Marcq P, Alcalay M, Matuchansky C. Acute perforation of colonic diverticula associated with short-term indomethacin. Lancet. 1978;2:1055-1056.
21. Langman MJS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. BMJ. 1985;290:347-349.
22. Corder A. Steroids, non-steroidal anti-inflammatory drugs, and serious septic complications of diverticular disease. BMJ. 1987;295:1238.
23. Wilson RG, Smith AN, Macintyre IMC. Complications of diverticular disease and non-steroidal anti-inflammatory drugs: a prospective study. Br J Surg. 1990;77: 1103-1104.
24. Campbell K, Steele RJC. Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study. Br J Surg. 1991;78:190-191.
25. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N Engl J Med. 1974;290:1158-1163.
26. Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol. 1988;41:35-45.
27. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;115:787-796.
28. Willett LR, Carson JL, Storm BL. Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugs. Drug Saf. 1994;10:170-181.
29. Rampton DS. Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract. Scand J Gastroenterol. 1987;22:1-4.
30. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992; 135:1114-1126.
31. Rimm EB, Giovannucci EL, Willett WC, et al. A prospective study of alcohol consumption and the risk of coronary disease in men. Lancet. 1991;338:464-468.
32. Parks TG. Natural history of diverticular disease of the colon: a review of 521 cases. BMJ. 1969;4:639-645.
33. Rothman KJ. Modern Epidemiology. Boston, Mass: Little Brown & Co; 1986.
34. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976;103:226-235.
35. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 1985;28:686-692.
36. Avron J. Reporting drug side effects: signals and noise. JAMA. 1990;263:1823.
37. Metz SA. Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man. Med Clin North Am. 1981;65:713-757.
38. Kalmykov SV, Kazimorvskaia VB, Batunova EV. Rapid chemiluminescence analysis of the effects of drugs on functional activity of phagocytosing blood cells. Farmakol Toksikol. 1989;52:97-100.
39. Huy DP, Roch-Arvellier M, Lenoir M, Muntaner D, Thuret A, Giroud JP. In-vitro and in-vivo effects of piroxicam on rat polymorphonuclear responsiveness after induction of two acute non-specific inflammatory reactions. Agents Action. 1986; 18:366-371.
40. Vane Jr. The mode of action of Aspirin and similar compounds. J Allergy Clin Immunol. 1976;58:691-712.
41. Gullikson GW, Sender M, Bass P. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity. J Pharmacol Exp Ther. 1982;220:236-242.
42. Issacs PET, Sladen GE, Filpie I. Mefenamic acid enteropathy. J Clin Pathol. 1987; 40:1221-1227.
43. Ravi S, Keat AC, Keat ECB. Colitis caused by nonsteroidal anti-inflammatory drugs. Postgrad Med J. 1986;62:773-776.
44. Kent TH, Cardelli RM, Stamler FW. Small intestinal ulcers and intestinal flora in rats given Indomethacin. Am J Pathol. 1969;53:237-249.
45. Satoh H, Guth PH, Grossman MI. Role of food in gastrointestinal ulceration produced by Indomethacin in the rat. Gastroenterology. 1982;83:210-215.
46. Brodie DA, Cook PG, Bauer BJ, Dagie GE. Indomethacin-induced intestinal lesions in the rat. Toxicol Appl Pharmacol. 1970;17:615-624.
47. Rex DK, Kumar S. Recognizing acetaminophen hepatotoxicity in chronic alcoholics. Postgrad Med. 1992;91:241-245.
48. Bonkovsky HL, Kane RE, Jones DP, Galinsky RE, Barner B. Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency. Hepatology. 1994;19:1141-1148.
49. Savage RL, Moller PW, Ballantyre CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal anti-inflammatory drug therapy. Arthritis Rheum. 1993;36:84-90.
50. Piper DW, McIntosh JH, Ariotti DE, Fenton BH, MacLennan R. Analgesic ingestion and chronic peptic ulcer. Gastroenterology. 1981;80:427-432.
51. Rampton DS, McNeil NI, Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut. 1983;24:187-189.
52. Flower RJ. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974; 26:33-67.
53. Robert A. Cytoprotection by prostaglandins. Gastroenterology. 1979;77: 761-769.
54. Lee YS. Diverticular disease of the large bowel in Singapore: an autopsy study. Dis Colon Rectum. 1986;29:330-335.
55. Chia JG, Chiantana CW, Ngoi SS, Goh PM. Ong CL. Trends of diverticular disease of the large bowel in a newly developed country. Dis Colon Rectum. 1991; 34:498-501.
56. Vajrabukka T, Saksornchai K, Jimakorn P. Diverticular disease of the colon in a far-eastern community. Dis Colon Rectum. 1980;23:151-154.